RAC1 and ovarian carcinoma: Extensive studies have confirmed the Rac1 oncogenic function, including gastric cancer [14–16], colon cancer [17, 18], breast cancer [19], lung cancer [20, 21], prostate cancer [22], ovarian cancer [23], and pancreatic cancer [24].